Status:
COMPLETED
A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease
Lead Sponsor:
Chinese University of Hong Kong
Collaborating Sponsors:
BUPA Foundation
Kwong Wah Hospital
Conditions:
Alzheimer's Disease
Eligibility:
All Genders
50+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to develop procedures for testing the effectiveness of curcumin on slowing Alzheimer's disease (AD) progression.
Detailed Description
A double-blind, randomized, clinical trial of 30 subjects will be carried out to develop procedures for testing the effectiveness of curcumin on slowing Alzheimer's disease (AD) progression. Curcumin ...
Eligibility Criteria
Inclusion
- Ethnic Chinese living in Hong Kong
- Progressive decline in memory and cognitive function for at least 6 months
- NINCDS-ADRDA diagnosis of possible or probable AD
- Mild to severe dementia with Cantonese version of MMSE scores between 0 and 28
- Informed consent from patient and/or caregiver
- Both elderly home residents and outpatients are eligible
- Patients may take any medication
Exclusion
- Anticoagulant or antiplatelet treatment or bleeding risk factors
- Currently smoking
- Other severe, end-stage illness
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00164749
Start Date
October 1 2004
End Date
July 1 2006
Last Update
April 30 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Shatin, Hong Kong